Autism biomarker seen as boon for new treatments
Researchers at the UCLA Center for Autism Research and Treatment have identified a signature brain-wave pattern for children with autism spectrum disorder related to a genetic condition known as Dup15q syndrome. The research team noted that this signature is among the first quantitative biomarkers identified in electroencephalogram tests discovered for any syndrome highly associated with autism spectrum disorder.

The number of children diagnosed with autism attributed to a genetic cause has rapidly increased. This is attributed to greater awareness of autism symptoms and advances in genetic testing methods. However, the increased diagnoses of genetic cases have outpaced doctors' ability to provide specific guidance or treatment plans for families. Researchers at the UCLA center study genetic syndromes associated with autism spectrum disorder in an effort to identify biomarkers that could lead to more targeted clinical care. Dup15q syndrome—a duplication of chromosome 15q11.2-q13.1—is among the most common genetic variants associated with autism disorders.


Read more at: http://medicalxpress.com/news/2017-01-autism-biomarker-boon-treatments.html#jCp
Like
Comment
Share